Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J01AA15
|
| gptkbp:CASNumber |
389139-89-3
|
| gptkbp:chemicalFormula |
C29H40N4O7
|
| gptkbp:developedBy |
gptkb:Paratek_Pharmaceuticals
|
| gptkbp:drugClass |
tetracycline antibiotic
|
| gptkbp:genericName |
omadacycline
|
| https://www.w3.org/2000/01/rdf-schema#label |
NUZYRA
|
| gptkbp:indication |
gptkb:community-acquired_bacterial_pneumonia
acute bacterial skin and skin structure infections |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:mechanismOfAction |
protein synthesis inhibitor
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting diarrhea |
| gptkbp:bfsParent |
gptkb:Zai_Lab
|
| gptkbp:bfsLayer |
7
|